DTIL
NASDAQ · Biotechnology
Precision Biosciences Inc
$6.24
+0.02 (+0.32%)
Open$6.21
Previous Close$6.22
Day High$6.26
Day Low$6.00
52W High$9.62
52W Low$3.53
Volume—
Avg Volume285.0K
Market Cap173.20M
P/E Ratio—
EPS$-2.80
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+391.8% upside
Current
$6.24
$6.24
Target
$30.69
$30.69
$21.79
$30.69 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 74.39M | 67.06M | 15.69M |
| Net Income | -99,266,847 | -80,537,422 | 557.5K |
| Profit Margin | -133.5% | -126.8% | 3.6% |
| EBITDA | -110,104,361 | -94,292,926 | 726.6K |
| Free Cash Flow | — | — | 441.5K |
| Rev Growth | +10.9% | +10.9% | -7.6% |
| Debt/Equity | 0.24 | 0.24 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |